Vivos Inc (RDGL): Agree as well. I think upon completing...

Send PM Follow Ignore

Re: wrinklesobw post# 172394

Saturday, 04/06/2024 11:13:04 AM

Saturday, April 06, 2024 11:13:04 AM

Agree as well. I think upon completing stage 2 requirements for IDE clinicals, they will meet requirements for uplist without the need for a RS.

Keep Last Read

Replies (1) Next 10 Prev Next

Form 8-K - Current report • Edgar (US Regulatory) • 12/27/2023 09:40:48 PM
Form QUALIF - Notice of Qualification [Regulation A] • Edgar (US Regulatory) • 12/07/2023 05:15:10 AM
Form 1-A POS - • Edgar (US Regulatory) • 11/27/2023 10:29:12 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/06/2023 04:28:46 PM
Form 1-A POS - • Edgar (US Regulatory) • 11/03/2023 09:03:20 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/19/2023 04:18:34 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/11/2023 10:33:58 AM
Form 1-A POS - • Edgar (US Regulatory) • 10/10/2023 04:05:36 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/04/2023 07:22:21 PM

InvestorsHub NewsWire

FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM

Only $200 per official company press release!